Published in J Virol on August 01, 1988
The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J Virol (1990) 6.08
Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J Virol (1993) 4.76
Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell (2010) 4.33
Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins. J Virol (2000) 3.39
Pandemic threat posed by avian influenza A viruses. Clin Microbiol Rev (2001) 3.33
Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. EMBO J (1997) 3.23
Activation of the M2 ion channel of influenza virus: a role for the transmembrane domain histidine residue. Biophys J (1995) 3.06
Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J Virol (2001) 3.05
Influenza A virus M2 ion channel protein: a structure-function analysis. J Virol (1994) 3.02
Specific structural alteration of the influenza haemagglutinin by amantadine. EMBO J (1990) 2.93
Influenza virus assembly and budding. Virology (2011) 2.90
Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J Virol (2007) 2.82
Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J Virol (1995) 2.70
Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J Virol (1993) 2.63
The biology of influenza viruses. Vaccine (2008) 2.58
Codon bias and frequency-dependent selection on the hemagglutinin epitopes of influenza A virus. Proc Natl Acad Sci U S A (2003) 2.54
Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg Infect Dis (2007) 2.36
Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport. J Virol (1994) 2.31
Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. PLoS Pathog (2009) 2.29
Structural proteins of equine arteritis virus. J Virol (1992) 2.23
The influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging. J Virol (2005) 2.23
Definitive assignment of proton selectivity and attoampere unitary current to the M2 ion channel protein of influenza A virus. J Virol (2001) 2.22
The active oligomeric state of the minimalistic influenza virus M2 ion channel is a tetramer. Proc Natl Acad Sci U S A (1997) 2.19
Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production. J Virol (2006) 2.18
The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding. J Virol (2008) 2.12
NS1 protein of influenza A virus down-regulates apoptosis. J Virol (2002) 2.12
The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly. J Virol (2006) 2.07
Refolding of a paramyxovirus F protein from prefusion to postfusion conformations observed by liposome binding and electron microscopy. Proc Natl Acad Sci U S A (2006) 2.03
The influenza virus hemagglutinin cytoplasmic tail is not essential for virus assembly or infectivity. EMBO J (1994) 2.01
Rescue of a synthetic chloramphenicol acetyltransferase RNA into influenza virus-like particles obtained from recombinant plasmids. J Virol (1996) 1.98
Cellular proteins in influenza virus particles. PLoS Pathog (2008) 1.96
Association of influenza virus matrix protein with ribonucleoproteins. J Virol (1999) 1.95
Ion selectivity and activation of the M2 ion channel of influenza virus. Biophys J (1996) 1.94
Infectious bronchitis virus E protein is targeted to the Golgi complex and directs release of virus-like particles. J Virol (2000) 1.90
Effect of cytoplasmic tail truncations on the activity of the M(2) ion channel of influenza A virus. J Virol (1999) 1.87
Increased virulence of a mouse-adapted variant of influenza A/FM/1/47 virus is controlled by mutations in genome segments 4, 5, 7, and 8. J Virol (1990) 1.84
The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus. J Cell Biol (1996) 1.83
Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments. Expert Rev Vaccines (2009) 1.83
Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J Virol (1990) 1.82
Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles. Proc Natl Acad Sci U S A (1991) 1.79
Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: roles of conserved residues in cell fusion. J Virol (1992) 1.76
Influenza virus m2 ion channel protein is necessary for filamentous virion formation. J Virol (2010) 1.73
Functional studies and modeling of pore-lining residue mutants of the influenza a virus M2 ion channel. Biochemistry (2010) 1.73
Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides. J Virol (1989) 1.73
Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein. Proc Natl Acad Sci U S A (1989) 1.69
Reverse genetics system for generation of an influenza A virus mutant containing a deletion of the carboxyl-terminal residue of M2 protein. J Virol (1995) 1.68
Prospects for universal influenza virus vaccine. Emerg Infect Dis (2006) 1.68
Analysis of the posttranslational modifications of the influenza virus M2 protein. J Virol (1995) 1.65
An influenza A (H1N1) virus, closely related to swine influenza virus, responsible for a fatal case of human influenza. J Virol (1994) 1.65
Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2. Virol J (2006) 1.64
Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses. PLoS One (2010) 1.64
Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity. J Virol (2001) 1.63
Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. PLoS Pathog (2012) 1.55
The influenza virus ion channel and maturation cofactor M2 is a cholesterol-binding protein. Eur Biophys J (2004) 1.54
Viral and cellular small integral membrane proteins can modify ion channels endogenous to Xenopus oocytes. Biophys J (1995) 1.51
Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2. J Virol (2005) 1.49
Human combinatorial antibody libraries to hepatitis B surface antigen. Proc Natl Acad Sci U S A (1992) 1.43
Expression of the influenza A virus M2 protein is restricted to apical surfaces of polarized epithelial cells. J Virol (1992) 1.42
Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses. Proc Natl Acad Sci U S A (2010) 1.42
Palmitylation of the influenza virus hemagglutinin (H3) is not essential for virus assembly or infectivity. J Virol (1996) 1.41
Influenza virus-like particles containing M2 induce broadly cross protective immunity. PLoS One (2011) 1.40
The 1A protein of respiratory syncytial virus is an integral membrane protein present as multiple, structurally distinct species. J Virol (1989) 1.32
Structural changes in Influenza virus at low pH characterized by cryo-electron tomography. J Virol (2012) 1.30
Heterosubtypic immunity to influenza A virus infection requires a properly diversified antibody repertoire. J Virol (2007) 1.26
An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses. Virol J (2010) 1.26
The M2 ectodomain is important for its incorporation into influenza A virions. J Virol (1998) 1.25
Influenza A (H3N2) outbreak, Nepal. Emerg Infect Dis (2005) 1.23
Influenza B virus BM2 protein is a crucial component for incorporation of viral ribonucleoprotein complex into virions during virus assembly. J Virol (2004) 1.19
Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis. Virol J (2009) 1.18
Conserved and host-specific features of influenza virion architecture. Nat Commun (2014) 1.15
Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse. Virol J (2007) 1.15
Structural maturation of the transmissible gastroenteritis coronavirus. J Virol (1999) 1.13
The morphology and composition of influenza A virus particles are not affected by low levels of M1 and M2 proteins in infected cells. J Virol (2005) 1.13
Influenza M2 proton channels. Biochim Biophys Acta (2010) 1.09
Characterization of inhibition of M2 ion channel activity by BL-1743, an inhibitor of influenza A virus. J Virol (1996) 1.09
Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza. PLoS One (2011) 1.08
Analysis of the pore structure of the influenza A virus M(2) ion channel by the substituted-cysteine accessibility method. J Virol (2000) 1.06
Evasion of influenza A viruses from innate and adaptive immune responses. Viruses (2012) 1.06
Novel vaccines against influenza viruses. Virus Res (2011) 1.04
Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases. Viruses (2014) 1.04
New vaccines against influenza virus. Clin Exp Vaccine Res (2013) 1.04
Subcellular localization and function of an epitope-tagged p7 viroporin in hepatitis C virus-producing cells. J Virol (2012) 1.03
Influenza C virus CM2 integral membrane glycoprotein is produced from a polypeptide precursor by cleavage of an internal signal sequence. Proc Natl Acad Sci U S A (1998) 1.03
Filamentous influenza virus enters cells via macropinocytosis. J Virol (2012) 1.02
A candidate dual vaccine against influenza and noroviruses. Vaccine (2011) 1.01
Palmitoylation of the influenza A virus M2 protein is not required for virus replication in vitro but contributes to virus virulence. J Virol (2009) 1.00
Transposition of domains between the M2 and HN viral membrane proteins results in polypeptides which can adopt more than one membrane orientation. J Cell Biol (1989) 1.00
Tyrosines in the influenza A virus M2 protein cytoplasmic tail are critical for production of infectious virus particles. J Virol (2010) 0.99
Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand. Clin Vaccine Immunol (2012) 0.99
Characterization of a second protein (CM2) encoded by RNA segment 6 of influenza C virus. J Virol (1997) 0.98
At low pH, influenza virus matrix protein M1 undergoes a conformational change prior to dissociating from the membrane. J Virol (2013) 0.98
Cytopathic mechanisms of HIV-1. Virol J (2007) 0.97
Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge. PLoS One (2012) 0.97
Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection. Antiviral Res (2013) 0.97
New aspects of influenza viruses. Clin Microbiol Rev (1992) 0.97
Influenza virus budding does not require a functional AAA+ ATPase, VPS4. Virus Res (2010) 0.97
Antiviral therapy: current concepts and practices. Clin Microbiol Rev (1992) 0.96
Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection. Mol Ther (2014) 0.95
Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (1975) 83.56
"Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem (1981) 71.15
Enhanced autoradiographic detection of 32P and 125I using intensifying screens and hypersensitized film. FEBS Lett (1977) 15.45
Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single-stranded DNA template. DNA (1984) 14.55
Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol (1981) 14.45
The molecular basis of the specific anti-influenza action of amantadine. EMBO J (1985) 7.08
Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell (1985) 6.44
Antiviral activity of antiserum specific for an influenza virus neuraminidase. J Virol (1968) 5.69
Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci U S A (1981) 5.57
Cloning of influenza cDNA ino M13: the sequence of the RNA segment encoding the A/PR/8/34 matrix protein. Nucleic Acids Res (1980) 4.75
Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice. J Virol (1968) 4.62
The gene structure and replication of influenza virus. Annu Rev Biochem (1983) 4.30
Evidence for a ninth influenza viral polypeptide. Virology (1978) 4.21
Monoclonal antibody characterization of the C proteins of heterogeneous nuclear ribonucleoprotein complexes in vertebrate cells. J Cell Biol (1984) 4.18
Subcellular compartmentalization of saccharide moieties in cultured normal and malignant cells. J Cell Biol (1980) 3.92
The polypeptide composition of influenza A viruses. Virology (1971) 3.79
Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins. Virology (1970) 3.58
Reduction in plaque size and reduction in plaque number as differing indices of influenza virus-antibody reactions. J Bacteriol (1966) 3.48
Studies on the formation of the influenza virus envelope. Virology (1974) 3.39
Polypeptides specified by the influenza virus genome I. Evidence for eight distinct gene products specified by fowl plague virus. Virology (1976) 3.20
Complete sequence analysis shows that the hemagglutinins of the H0 and H2 subtypes of human influenza virus are closely related. Virology (1981) 3.07
Nucleotide sequence coding for the "signal peptide" and N terminus of the hemagglutinin from an asian (H2N2) strain of influenza virus. Virology (1979) 3.01
Functional significance of sialidose during influenza virus multiplication. Virology (1966) 2.94
Segment 8 of the influenza virus genome is unique in coding for two polypeptides. Proc Natl Acad Sci U S A (1979) 2.58
Characterization of the influenza virus M2 integral membrane protein and expression at the infected-cell surface from cloned cDNA. J Virol (1985) 2.58
Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus. Virology (1981) 2.26
Isolation and characterization of influenza virus recombinants with high and low neuraminidase activity. Use of 2-(3'-methoxyphenyl)-n-acetylneuraminic acid to identify cloned populations. Virology (1974) 2.19
Molecular basis of resistance of influenza A viruses to amantadine. J Antimicrob Chemother (1986) 2.04
Susceptibility of influenza A viruses to amantadine is influenced by the gene coding for M protein. J Virol (1978) 1.99
Conservation of the influenza virus membrane protein (M1) amino acid sequence and an open reading frame of RNA segment 7 encoding a second protein (M2) in H1N1 and H3N2 strains. Virology (1981) 1.94
Amantadine-resistance as a genetic marker for influenza viruses. J Gen Virol (1977) 1.92
Use of antibodies directed against synthetic peptides for identifying cDNA clones, establishing reading frames, and deducing the gene order of measles virus. J Virol (1985) 1.75
Nucleotide sequence of fowl plague virus RNA segment 7. J Gen Virol (1982) 1.65
Evolution of the nucleotide sequence of influenza virus RNA segment 7 during drift of the H3N2 subtype. Gene (1983) 1.64
The matrix protein gene determines amantadine-sensitivity of influenza viruses. J Gen Virol (1979) 1.54
Characterization of a gene coding for M proteins which is involved in host range restriction of an avian influenza A virus in monkeys. J Virol (1986) 1.50
Antigenic characterization of influenza A virus matrix protein with monoclonal antibodies. J Virol (1984) 1.49
Proteolytic cleavage of the hemagglutinin polypeptide of influenza virus. Function of the uncleaved polypeptide HA. Virology (1973) 1.43
The significance of influenza virus neuraminidase in immunity. J Gen Virol (1974) 1.30
Conformational changes at topologically distinct antigenic sites on the influenza A/PR/8/34 virus HA molecule are induced by the binding of monoclonal antibodies. Virology (1982) 1.30
Nucleotide sequence of RNA segment 7 of influenza B/Singapore/222/79: maintenance of a second large open reading frame. Virology (1986) 1.09
Influenza virus M2 protein has ion channel activity. Cell (1992) 8.52
Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell (1985) 6.44
Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci U S A (1981) 5.57
Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J Virol (1993) 4.76
Folding and assembly of viral membrane proteins. Virology (1993) 4.63
The gene structure and replication of influenza virus. Annu Rev Biochem (1983) 4.30
Evidence for a ninth influenza viral polypeptide. Virology (1978) 4.21
Sequence of interrupted and uninterrupted mRNAs and cloned DNA coding for the two overlapping nonstructural proteins of influenza virus. Cell (1980) 4.18
Structural basis for paramyxovirus-mediated membrane fusion. Mol Cell (1999) 4.17
A functionally defined model for the M2 proton channel of influenza A virus suggests a mechanism for its ion selectivity. Proc Natl Acad Sci U S A (1997) 4.03
Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell (1988) 3.98
Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology (1991) 3.83
Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion. EMBO J (2001) 3.76
Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology (1997) 3.58
Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins. J Virol (2000) 3.39
The synthesis of sendai virus polypeptides in infected cells. Virology (1976) 3.26
Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. EMBO J (1997) 3.23
Polypeptides specified by the influenza virus genome I. Evidence for eight distinct gene products specified by fowl plague virus. Virology (1976) 3.20
Synthesis of influenza virus proteins in infected cells: translation of viral polypeptides, including three P polypeptides, from RNA produced by primary transcription. Virology (1976) 3.13
A previously unrecognized influenza B virus glycoprotein from a bicistronic mRNA that also encodes the viral neuraminidase. Proc Natl Acad Sci U S A (1983) 3.08
Activation of the M2 ion channel of influenza virus: a role for the transmembrane domain histidine residue. Biophys J (1995) 3.06
Influenza A virus M2 ion channel protein: a structure-function analysis. J Virol (1994) 3.02
The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology (2001) 2.83
Fusion protein of the paramyxovirus simian virus 5: nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein. Proc Natl Acad Sci U S A (1984) 2.82
A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41. Virology (1998) 2.61
Mapping of the two overlapping genes for polypeptides NS1 and NS2 on RNA segment 8 of influenza virus genome. Proc Natl Acad Sci U S A (1980) 2.60
Segment 8 of the influenza virus genome is unique in coding for two polypeptides. Proc Natl Acad Sci U S A (1979) 2.58
Characterization of the influenza virus M2 integral membrane protein and expression at the infected-cell surface from cloned cDNA. J Virol (1985) 2.58
Expression at the cell surface of biologically active fusion and hemagglutinin/neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA. Proc Natl Acad Sci U S A (1985) 2.56
The synthesis of Sendai virus polypeptides in infected cells. III. Phosphorylation of polypeptides. Virology (1977) 2.48
Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia. J Virol (1992) 2.47
The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology (1998) 2.43
The paramyxovirus SV5 V protein binds two atoms of zinc and is a structural component of virions. Virology (1995) 2.40
Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation. Virology (2000) 2.39
Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A (1979) 2.33
Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport. J Virol (1994) 2.31
Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus. Virology (1981) 2.26
Polypeptide synthesis in simian virus 5-infected cells. J Virol (1977) 2.20
The active oligomeric state of the minimalistic influenza virus M2 ion channel is a tetramer. Proc Natl Acad Sci U S A (1997) 2.19
The remarkable coding strategy of borna disease virus: a new member of the nonsegmented negative strand RNA viruses. Virology (1995) 2.17
Determination by peptide mapping of the unique polypeptides in Sendai virions and infected cells. Virology (1978) 2.17
Mechanism for proton conduction of the M(2) ion channel of influenza A virus. J Biol Chem (2000) 2.13
The V protein of the paramyxovirus SV5 interacts with damage-specific DNA binding protein. Virology (1998) 2.13
Topology of eukaryotic type II membrane proteins: importance of N-terminal positively charged residues flanking the hydrophobic domain. Cell (1991) 2.11
The influenza virus hemagglutinin cytoplasmic tail is not essential for virus assembly or infectivity. EMBO J (1994) 2.01
Direct measurement of the influenza A virus M2 protein ion channel activity in mammalian cells. Virology (1994) 1.99
Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells. J Virol (2001) 1.95
Eukaryotic coupled translation of tandem cistrons: identification of the influenza B virus BM2 polypeptide. EMBO J (1990) 1.95
Ion selectivity and activation of the M2 ion channel of influenza virus. Biophys J (1996) 1.94
Conservation of the influenza virus membrane protein (M1) amino acid sequence and an open reading frame of RNA segment 7 encoding a second protein (M2) in H1N1 and H3N2 strains. Virology (1981) 1.94
Reconstitution of the influenza virus M2 ion channel in lipid bilayers. J Membr Biol (1994) 1.91
Permeation and activation of the M2 ion channel of influenza A virus. J Biol Chem (2000) 1.90
Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J Virol (1995) 1.89
Analysis and gene assignment of mRNAs of a paramyxovirus, simian virus 5. Virology (1984) 1.88
Characterization of the membrane association of the influenza virus matrix protein in living cells. Virology (1996) 1.87
Spliced and unspliced messenger RNAs synthesized from cloned influenza virus M DNA in an SV40 vector: expression of the influenza virus membrane protein (M1). Virology (1982) 1.87
Hemagglutinin-neuraminidase protein of the paramyxovirus simian virus 5: nucleotide sequence of the mRNA predicts an N-terminal membrane anchor. J Virol (1985) 1.87
Effect of cytoplasmic tail truncations on the activity of the M(2) ion channel of influenza A virus. J Virol (1999) 1.87
The paramyxovirus simian virus 5 V protein slows progression of the cell cycle. J Virol (2000) 1.85
Complete nucleotide sequence of the neuraminidase gene of influenza B virus. Proc Natl Acad Sci U S A (1982) 1.85
The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus. J Cell Biol (1996) 1.83
Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J Virol (1990) 1.82
Influenza B virus genome: sequences and structural organization of RNA segment 8 and the mRNAs coding for the NS1 and NS2 proteins. J Virol (1982) 1.81
Virus membrane fusion proteins: biological machines that undergo a metamorphosis. Biosci Rep (2000) 1.79
In vitro synthesis of structural and nonstructural proteins of Sendai and SV5 viruses. Virology (1980) 1.78
Escaping from the cell: assembly and budding of negative-strand RNA viruses. Curr Top Microbiol Immunol (2004) 1.77
Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: roles of conserved residues in cell fusion. J Virol (1992) 1.76
Alterations to influenza virus hemagglutinin cytoplasmic tail modulate virus infectivity. J Virol (1992) 1.74
Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein. Proc Natl Acad Sci U S A (1989) 1.69
The polypeptides of canine distemper virus: synthesis in infected cells and relatedness to the polypeptides of other morbilliviruses. Virology (1980) 1.69
RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts. J Virol (1990) 1.68
Analysis of the relationship between cleavability of a paramyxovirus fusion protein and length of the connecting peptide. J Virol (1989) 1.68
Ability of the hydrophobic fusion-related external domain of a paramyxovirus F protein to act as a membrane anchor. Cell (1987) 1.68
Cu(II) inhibition of the proton translocation machinery of the influenza A virus M2 protein. J Biol Chem (1999) 1.67
Different roles of individual N-linked oligosaccharide chains in folding, assembly, and transport of the simian virus 5 hemagglutinin-neuraminidase. Mol Cell Biol (1990) 1.66
Analysis of the posttranslational modifications of the influenza virus M2 protein. J Virol (1995) 1.65
Involvement of the cytoplasmic domain of the hemagglutinin-neuraminidase protein in assembly of the paramyxovirus simian virus 5. J Virol (1999) 1.64
Studies with cross-linking reagents on the oligomeric form of the paramyxovirus fusion protein. Virology (1994) 1.63
The cytoplasmic tails of the influenza virus spike glycoproteins are required for normal genome packaging. Virology (2000) 1.61
The influenza virus M2 ion channel protein: probing the structure of the transmembrane domain in intact cells by using engineered disulfide cross-linking. Virology (1999) 1.59
Infection with paramyxoviruses stimulates synthesis of cellular polypeptides that are also stimulated in cells transformed by Rous sarcoma virus or deprived of glucose. Proc Natl Acad Sci U S A (1978) 1.55
Identification and predicted sequence of a previously unrecognized small hydrophobic protein, SH, of the paramyxovirus simian virus 5. J Virol (1985) 1.53
Viral and cellular small integral membrane proteins can modify ion channels endogenous to Xenopus oocytes. Biophys J (1995) 1.51
Effect of mutations and deletions in a bicistronic mRNA on the synthesis of influenza B virus NB and NA glycoproteins. J Virol (1989) 1.50
Synthesis of influenza virus polypeptides in cells resistant to alpha-amanitin: evidence for the involvement of cellular RNA polymerase II in virus replication. J Virol (1977) 1.49
The paramyxovirus SV5 small hydrophobic (SH) protein is not essential for virus growth in tissue culture cells. Virology (1998) 1.46
Expression of unspliced NS1 mRNA, spliced NS2 mRNA, and a spliced chimera mRNA from cloned influenza virus NS DNA in an SV40 vector. Virology (1984) 1.46
The SH integral membrane protein of the paramyxovirus simian virus 5 is required to block apoptosis in MDBK cells. J Virol (2001) 1.46
Virus replication in engineered human cells that do not respond to interferons. J Virol (2003) 1.44
Truncation of the COOH-terminal region of the paramyxovirus SV5 fusion protein leads to hemifusion but not complete fusion. J Cell Biol (1996) 1.44
Integration of a small integral membrane protein, M2, of influenza virus into the endoplasmic reticulum: analysis of the internal signal-anchor domain of a protein with an ectoplasmic NH2 terminus. J Cell Biol (1988) 1.44
Expression of the influenza A virus M2 protein is restricted to apical surfaces of polarized epithelial cells. J Virol (1992) 1.42
Palmitylation of the influenza virus hemagglutinin (H3) is not essential for virus assembly or infectivity. J Virol (1996) 1.41
Death by influenza virus protein. Nat Med (2001) 1.36
Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly. Virology (1995) 1.35
The role of the cytoplasmic tail region of influenza virus hemagglutinin in formation and growth of fusion pores. Virology (1997) 1.31